Refractive Surgery News

MILAN — In a series of complex post-radial keratotomy eyes, the small-aperture IOL from AcuFocus resulted in good unaided vision and increased depth of focus.

MONTEREY, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Cathleen M. McCabe, MD, discusses trial data for Vuity in the correction of presbyopia.

Noncontact air-puff tonometry is an effective method of measuring IOP after ICL implantation, but it is better avoided in cases of excessive high vault, shallow anterior chamber, narrow anterior chamber angle and soft cornea.

Since the FDA approval and release of Vuity in late 2021, physicians and patients now have a new option for presbyopia treatment.

The first patient has been enrolled in a study of the Technolas Teneo excimer laser for LASIK surgery in patients with hyperopia with astigmatism, according to a press release.

Over the past decade, femtosecond laser technology has matured in both corneal and cataract applications to be more refined and user friendly, creating new opportunities for minimally invasive procedures.

WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Amar Agarwal, MS, FRCS, FRCOphth, discusses customized pinhole pupilloplasty as an effective treatment for astigmatism.

Presbyopia is a ubiquitous and progressive symptom of aging that was previously only treatable with reading glasses, contacts or surgery, but patients now have a new option to help their aging eyes: eye drops.

Vuity is our first FDA-approved pharmaceutical agent labeled for the treatment of a refractive error, presbyopia.

The future for presbyopia is bright no matter what side you are on. For drops, the benefits are that they are nonsurgical and well tolerated, and the risk profile is relatively safe. The con is that for many patients, they will not work.